About

Resverlogix is a late‑stage clinical biotechnology firm developing epigenetic therapies such as apabetalone for chronic diseases, focusing on cardiovascular and metabolic conditions, and partnering with pharmaceutical, physician, and payer stakeholders to deliver value‑based health solutions. The company conducts Phase 3 trials like BETonMACE and collaborates with key payer groups to improve patient outcomes.

Details

Areas served
San Francisco, CA, USA

Products & services in Calgary

Technical university Pharmaceutical production Business development Pharmaceutical product Research development

Links

Similar companies nearby

Related searches: Business development in Lethbridge · Business development in Tsuu T'ina · Business development in Crossfield · Business development in Cochrane · Business development in Airdrie